Position in RPRX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,224,025
+$513,720 QoQ
Shares Held
57,500
+1.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#233
of 641 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEARLE & CO. holds $3,260,836 across 2 Biotechnology names. RPRX ranks #1 (98.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
57,500 | $3,224,025 | |
| 2 | HRTX |
Heron Therapeutics, Inc. /De/
|
86,250 | $36,811 |
All Filings in RPRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,224,025 | 57,500 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,710,305 | 56,500 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,221,800 | 57,500 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,028,600 | 57,500 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,071,725 | 57,500 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,789,975 | 57,500 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,466,825 | 57,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,626,675 | 57,500 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,516,275 | 57,500 | Shares | Sole | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||